Timing of androgen-deprivation therapy for prostate cancer: still a long way to go. [electronic resource]
- The Lancet. Oncology 08 2016
- e313 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
1474-5488
10.1016/S1470-2045(16)30309-6 doi
Androgen Antagonists Humans Male Prostatic Neoplasms